|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 25.58 USD | -0.16% |
|
+8.16% | -6.02% |
Share class: Beam Therapeutics Inc.
| Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
|---|---|---|---|---|---|
| Stock A | 1 | 82,415,619 | 81,183,524 ( 98.51 %) | 0 | 98.51 % |
Major shareholders: Beam Therapeutics Inc.
| Name | Equities | % | Valuation |
|---|---|---|---|
Farallon Capital Management LLC
9.601
%
| 7,913,123 | 9.601 % | 211 M $ |
Vanguard Fiduciary Trust Co.
9.586
%
| 7,900,379 | 9.586 % | 211 M $ |
ARK Investment Management LLC
9.253
%
| 7,626,139 | 9.253 % | 203 M $ |
BlackRock Advisors LLC
8.430
%
| 6,948,001 | 8.430 % | 185 M $ |
ARCH Venture Partners LLC
6.604
%
| 5,443,039 | 6.604 % | 145 M $ |
State Street Corp.
4.237
%
| 3,492,155 | 4.237 % | 93 M $ |
Fidelity Management & Research Co. LLC
3.966
%
| 3,268,252 | 3.966 % | 87 M $ |
Milky Way Investments Group Ltd.
2.751
%
| 2,266,934 | 2.751 % | 60 M $ |
Nikko Asset Management Americas, Inc.
2.699
%
| 2,224,415 | 2.699 % | 59 M $ |
Temasek Holdings Pte Ltd.
2.200
%
| 1,812,972 | 2.200 % | 48 M $ |
| ░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
| ░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
| ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
| ░░░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
| ░░░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
| ░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
| ░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
| ░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
| ░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
| ░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
| ░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
| ░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
| ░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
| ░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
| ░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
Breakdown by shareholder type
| Institutional | 80.56% |
| Other | 6.73% |
| State Street Corp. | 4.24% |
| Individuals | 2.00% |
| Alphabet, Inc. | 0.39% |
| Manulife Financial Corp. | 0.17% |
| Schweizerische Nationalbank | 0.17% |
| Corebridge Financial, Inc. | 0.05% |
| Governments | 0.01% |
| Unknown | 5.68% |
Based on 1000 largest holdings
Geographical origin of shareholders
| United States | 77.25% |
| United Kingdom | 6.82% |
| Singapore | 2.20% |
| Individuals | 2.00% |
| Switzerland | 1.96% |
| Australia | 1.21% |
| Ireland | 0.72% |
| China | 0.53% |
| Norway | 0.51% |
| Canada | 0.48% |
| France | 0.23% |
| Denmark | 0.11% |
| Luxembourg | 0.08% |
| Austria | 0.08% |
| Germany | 0.06% |
| Cayman Islands | 0.04% |
| Sweden | 0.02% |
| Japan | 0.01% |
Based on 1000 largest holdings
Employees
461
Calendar
2024-11-03
- Q3 2024 Earnings Release (Projected)
- Stock Market
- Equities
- BEAM Stock
- Company Beam Therapeutics Inc.
- Share ownership